These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9723432)

  • 1. Tacrolimus is superior to cyclosporine in liver transplantation.
    Busuttil RW; Holt CD
    Transplant Proc; 1998 Aug; 30(5):2174-8. PubMed ID: 9723432
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressant switching between cyclosporine and tacrolimus after liver transplantation.
    Hashikura Y; Kawasaki S; Matsunami H; Terada M; Ikegami T; Nakazawa Y; Watanabe M; Chisuwa H; Kamijima T; Takagi S; Makuuchi M
    Transplant Proc; 1996 Apr; 28(2):1034-5. PubMed ID: 8623218
    [No Abstract]   [Full Text] [Related]  

  • 4. Usefulness of the switch to tacrolimus in liver transplantation.
    González-Pinto I; Alonso O; Loinaz C; Gómez R; Rodríguez-Cañete A; Rodríguez F; Pérez-Saborido B; Paseiro G; Moreno-González E
    Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653
    [No Abstract]   [Full Text] [Related]  

  • 5. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
    Mühlbacher F;
    Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus (FK506) is superior to cyclosporine in liver transplantation.
    Busuttil RW; Holt CD
    Transplant Proc; 1997; 29(1-2):534-8. PubMed ID: 9123119
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.
    Wiesner RH
    Transplant Proc; 1998 Jun; 30(4):1399-400. PubMed ID: 9636565
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus in solid organ transplantation: an update.
    Shapiro R
    Transplant Proc; 1999 Sep; 31(6):2203-5. PubMed ID: 10500545
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomised trialomania? The multicentre liver transplant trials of tacrolimus.
    Starzl TE; Donner A; Eliasziw M; Stitt L; Meier P; Fung JJ; McMichael JP; Todo S
    Lancet; 1995 Nov; 346(8986):1346-50. PubMed ID: 7475777
    [No Abstract]   [Full Text] [Related]  

  • 10. Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation.
    Bechstein WO; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Ericzon BG; Bismuth H
    Transplant Proc; 1996 Apr; 28(2):1008-10. PubMed ID: 8623211
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
    [No Abstract]   [Full Text] [Related]  

  • 12. More effective immunosuppression with the use of FK506 after liver transplantation.
    Lo CM; Fan ST; Liu CL; Ng IO; Lam BK; Yong BH; Lai CL; Lau GK; Wong J
    Transplant Proc; 2000 Nov; 32(7):2269-70. PubMed ID: 11120161
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P; Rossi G; Latham L; Caccamo L; Gatti S; Maggi U; Melada E; Paone G; Doglia M; Vannelli A; Fassati LR
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].
    Arnold JC; Theilmann L
    Z Gastroenterol; 1995 Oct; 33(10):624-5. PubMed ID: 7502559
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduction in hospital stay after liver transplantation.
    Harrison DM; Stewart AS; Koneru B; Holman MJ
    Transplant Proc; 1996 Apr; 28(2):896. PubMed ID: 8623451
    [No Abstract]   [Full Text] [Related]  

  • 16. Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study.
    Pichlmayr R; Winkler M; Neuhaus P; McMaster P; Calne R; Otto G; Williams R; Groth CG; Bismuth H
    Transplant Proc; 1997 Aug; 29(5):2499-502. PubMed ID: 9270825
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoral is superior to FK 506 in liver transplantation.
    Levy GA
    Transplant Proc; 1998 Aug; 30(5):1812-5. PubMed ID: 9723293
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy.
    Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
    Transplant Proc; 2000 Jun; 32(4):709-10. PubMed ID: 10856553
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles.
    Henry ML
    Clin Transplant; 1999 Jun; 13(3):209-20. PubMed ID: 10383101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of tacrolimus for initial rejection episodes after liver transplantation.
    Millis JM; Cronin DC; Newell KA; Bruce DS; Woodle ES; Grewal HP; Loss GE; Lissoos T; Conjeevaram H; Schiano T; O'Laughlin R; Charette J; McNaughton M; Baker AL; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1407-8. PubMed ID: 9636569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.